Tinea Capitis
📧 Sign up to get email alerts when something new happens for Tinea Capitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Children. [NA]
A completed clinical trial compares the efficacy of pulse itraconazole versus terbinafine therapy for treating Tinea capitis in children.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children [NA]
A pediatric clinical trial comparing continuous versus pulsed itraconazole dosing for tinea capitis, currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis
Shandong University is conducting a population pharmacokinetic study of terbinafine in children with tinea capitis. The trial is currently r…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Trichoscopic Predictors of Treatment Response in Tinea Capitis: A Prospective Study
A prospective clinical trial from Istanbul Medeniyet University investigates whether trichoscopic features can predict treatment response in…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the efficacy and safety of a topical amphotericin B solution for resistant tinea capitis in children a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-20FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Clinical and Laboratory Evaluation of Antifungal Resistance in Tinea Capitis [Phase 1]
Phase 1 clinical trial evaluating antifungal resistance in tinea capitis; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: A Study Of Diflucan In Children With Ringworm Of The Scalp [Phase 3]
Phase 3 clinical trial of Diflucan (fluconazole) in children with ringworm of the scalp (tinea capitis) completed.
-
FDA approval · 2020-02-18FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
The FDA approved a supplemental application for Ketoconazole filed by Thirty Madison Inc, resulting in updates to the Ketoconazole product l…
-
FDA approval · 2018-12-26FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Sandoz Inc)
FDA approved a generic version of griseofulvin (Ultramicrosize Griseofulvin) from Sandoz Inc under an Original Application (ANDA 202805) for…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Terbinafine Compared to Griseofulvin in Children With Tinea Capitis [Phase 3]
Phase 3 trial comparing Terbinafine to Griseofulvin in children with tinea capitis has completed.
-
CLINICAL_TRIALS withdrawal · 2016-09-09Clinical Trial Update: Safety and Efficacy of NAFT900 in Children With Tinea Capitis [Phase 2]
A Phase 2 trial evaluating NAFT900 for safety and efficacy in children with tinea capitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Design and Clinical Evaluation of a School Meal With Deworming Properties [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating a school meal with deworming properties conducted by the Kenya Medical Research Institute, studying e…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai [Phase 2]
This clinical trial update reports the completion of Phase 2 evaluation of Kandhaga Rasayanam in Padarthamarai for various tinea infections,…
-
FDA approval · 2014-01-09FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC via an Original Application.
-
FDA approval · 2012-10-22FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Sigmapharm Laboratories, LLC)
FDA approved the original application (ANDA) for ULTRAMICROSIZE GRISEOFULVIN from Sigmapharm Laboratories, LLC.
-
FDA approval · 2012-06-28FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Dr.Reddys Laboratories Limited)
FDA approved a supplemental application for terbinafine hydrochloride tablets (250 mg) from Dr. Reddy's Laboratories Limited, authorizing a …
-
FDA approval · 2012-04-10FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
FDA approves Breckenridge Pharmaceutical's supplemental application for terbinafine hydrochloride, a generic antifungal, to market an additi…
-
FDA approval · 2012-02-29FDA Approved: CICLOPIROX — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's ciclopirox as a generic product under an original ANDA application.
-
FDA approval · 2011-12-14FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Terbinafine Hydrochloride by Bionpharma Inc., signaling an approval of a supplemental submission…
-
FDA approval · 2011-09-21FDA Approved: TERBINAFINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Terbinafine hydrochloride from NorthStar Rx LLC, updating the generic product's approval.
-
CLINICAL_TRIALS research · 2011-09-19Clinical Trial Update: The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation
A completed clinical trial investigating the natural course of Trichophyton tonsurans carriage and infection in Tinea capitis using molecula…
-
FDA approval · 2010-10-08FDA Approved: GRISEOFULVIN — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Griseofulvin from Cosette Pharmaceuticals in an Original Application (ANDA065438). This approval provides a generic Griseofulvi…
-
FDA approval · 2010-02-16FDA Approved: CICLOPIROX — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals Ltd's Ciclopirox topical product under Original Application (ANDA 078594), authorizing its m…
-
CLINICAL_TRIALS research · 2008-07-09Clinical Trial Update: Selenium Sulfide, Ketoconazole and Ciclopirox Shampoo as Additional Treatments for Tinea Capitis (Scalp Ringworm) [NA]
Clinical trial update on using selenium sulfide, ketoconazole, and ciclopirox shampoos as additional treatments for tinea capitis (scalp rin…